Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis
暂无分享,去创建一个
L R Muenz | H. Wishart | R. Benedict | B. Weinstock-Guttman | H. Westervelt | L. Krupp | A. Goodman | C. Christodoulou | S. Rizvi | R H B Benedict | B Weinstock-Guttman | S R Schwid | P. Melville | W. Scherl | L. Muenz | L B Krupp | C Christodoulou | P Melville | W F Scherl | L-Y Pai | D He | A Goodman | S Rizvi | H J Westervelt | H Wishart | S. Schwid | R. Benedict | D. He | L. Krupp | L. Pai
[1] B. Oken,et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis , 2007, Multiple sclerosis.
[2] R. Benedict,et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.
[3] R. Benedict,et al. Reliable screening for neuropsychological impairment in multiple sclerosis , 2004, Multiple sclerosis.
[4] M. Bear,et al. The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial , 2009, Journal of Neurology.
[5] H. Levin. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1993 .
[6] R. Mohs,et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease , 1998, Neurology.
[7] Stephen M. Rao,et al. The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory. , 1998, Journal of personality assessment.
[8] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[9] K. Heilman,et al. Donepezil improved memory in multiple sclerosis in a randomized clinical trial , 2005, Neurology.
[10] Ralph H B Benedict,et al. Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.
[11] Kyle C. Kern,et al. Regional hippocampal atrophy in multiple sclerosis. , 2008, Brain : a journal of neurology.
[12] L. Krupp,et al. Treatment of Cognitive Impairment in Multiple Sclerosis , 2008, CNS Drugs.
[13] S. Stewart,et al. Cognitive and sedative effects of benzodiazepine use. , 2002, Current pharmaceutical design.
[14] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[15] S. Rao,et al. Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.
[16] R. Benedict. Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis , 2009, Multiple sclerosis.
[17] V. Shaygannejad,et al. Effects of Rivastigmine on Memory and Cognition in Multiple Sclerosis , 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[18] Ron Dumont,et al. Delis‐Kaplan Executive Function System , 2008 .
[19] D G Altman,et al. Confidence intervals for the number needed to treat , 1998, BMJ.
[20] H J Hannay,et al. Visual perception of line direction in patients with unilateral brain disease , 1975, Neurology.
[21] S. Salloway,et al. Efficacy and Tolerability of Donepezil in Vascular Dementia: Positive Results of a 24-Week, Multicenter, International, Randomized, Placebo-Controlled Clinical Trial , 2003, Stroke.
[22] Y. Agid,et al. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[23] M. Sliwinski,et al. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. , 1996, Archives of neurology.
[24] H.-J. Möller,et al. The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 , 1999, Dementia and Geriatric Cognitive Disorders.
[25] J. Yesavage,et al. Donepezil and flight simulator performance: Effects on retention of complex skills , 2002, Neurology.
[26] J. Grafman,et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. , 2000, Annals of neurology.
[27] Stephen M. Rao,et al. Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.
[28] Eben S. Schwartz,et al. Validity of the California Verbal Learning Test–II in Multiple Sclerosis , 2010, The Clinical neuropsychologist.
[29] I. Heuser,et al. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. , 2010, Pharmacological research.
[30] A. Feinstein,et al. Detecting Cognitive Dysfunction in Multiple Sclerosis with a Magnetic Resonance Imaging Rating Scale: A Pilot Study , 2005, CNS Spectrums.